Effect of different treatments on serum level of ALT, AST, ALP, and total bilirubina.
Groups | Serum AST activity (U mL−1) | Serum ALT activity (U mL−1) | Serum ALP activity (U L−1) | Total bilirubin (mg dL−1) |
---|---|---|---|---|
Normal control | 23.33 ± 0.89a | 53.83 ± 1.35abc | 110.17 ± 5.25a | 0.77 ± 0.01a |
STZ-diabetic rats | 58.66 ± 1.801f | 147.17 ± 5.63f | 232.77 ± 10.48f | 1.43 ± 0.04d |
Diabetic rats treated with ethanolic extracts of leaves of | ||||
cv. Festival | 35.2 ± 1.08b | 50.82 ± 2.25a | 140.67 ± 7.31cd | 0.911 ± 0.01b |
cv. Red Merlin | 36.37 ± 1.13bc | 51.32 ± 1.94ab | 144.35 ± 5.33cd | 0.92 ± 0.01b |
Diabetic rats treated with ethanolic extracts of fruits of | ||||
cv. Festival | 39.55 ± 0.801cd | 55.7 ± 1.68abc | 162.97 ± 7.33de | 1.001 ± 0.03c |
cv. Red Merlin | 41.17 ± 1.29de | 56.87 ± 2.33abcd | 163 ± 6.13de | 1.015 ± 0.03c |
Diabetic rats treated with gliclazide | 26.85 ± 1.02a | 64.6 ± 1.62de | 130.6 ± 4.82b | 0.871 ± 0.02b |
Each value represents the mean of 6 rats ± S.E. (standard error). Values within a column followed by different letters are significantly different (P < 0.05) by SPSS Duncan. Where STZ: streptozotocin; AST: aspartate transaminase; ALT: alanine transaminase; ALP: alkaline phosphatase.